Malignant Peritoneal Mesothelioma
📧 Sign up to get email alerts when something new happens for Malignant Peritoneal Mesothelioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Dual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal Mesothelioma [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating dual-target MSLN/FAP CAR-NK cells for malignant pleural and peritoneal mesothelioma; the study is c…
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: CT-95 in Advanced Cancers Associated With Mesothelin Expression [Phase 1]
Phase 1 trial CT-95 for mesothelin-expressing tumors is currently recruiting across multiple indications, including epithelial ovarian cance…
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma [Phase 2]
This clinical trial update describes an ongoing Phase 2 study evaluating additional chemotherapy after surgery for malignant peritoneal meso…
-
CLINICAL_TRIALS research · 2024-08-07Clinical Trial Update: Sintilimab, Bevacizumab, Pemetrexed, and Cisplatin for Unresectable MPeM [Phase 2]
Phase 2 clinical trial evaluating a four-drug combination of sintilimab, bevacizumab, pemetrexed, and cisplatin for unresectable malignant p…
-
CLINICAL_TRIALS trial_result · 2024-01-03Clinical Trial Update: A Study of Immunotherapy Drugs Nivolumab and Ipilimumab in Patients w/Resectable Malignant Peritoneal Mesothelioma [Phase 2]
Phase 2 clinical trial of nivolumab and ipilimumab in patients with resectable malignant peritoneal mesothelioma has completed with posted r…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-07-09Clinical Trial Update: Efficacy of a Maintenance Treatment With TALAzoparib Following First Line Platinum-based Chemotherapy in Malignant MESOthelioma [Phase 2]
Phase 2 trial evaluating maintenance TALAzoparib after first-line platinum chemotherapy in advanced malignant pleural or peritoneal mesothel…
-
CLINICAL_TRIALS trial_result · 2020-01-28Clinical Trial Update: αDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating αDC1 vaccine with a chemokine modulatory regimen as adjuvant therapy for peritoneal surface malignancies…
-
CLINICAL_TRIALS trial_result · 2019-11-22Clinical Trial Update: Mesothelin-Targeted Immunotoxin LMB-100 in Combination With SEL-110 in Subjects With Malignant Pleural or Peritoneal Mesothelioma [Phase 1]
Phase 1 trial evaluating LMB-100 in combination with SEL-110 for mesothelioma has been terminated; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2018-10-16Clinical Trial Update: Erlotinib Hydrochloride in Treating Patients With Malignant Peritoneal Mesothelioma [Phase 2]
Phase 2 clinical trial evaluating erlotinib hydrochloride for malignant peritoneal mesothelioma has completed with posted results.
-
CLINICAL_TRIALS research · 2014-01-06Clinical Trial Update: Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer [Phase 2]
A Phase 2 clinical trial update exploring surgery, chemotherapy, and radiation therapy for malignant peritoneal mesothelioma.
-
CLINICAL_TRIALS research · 2011-10-31Clinical Trial Update: Velcade and Eloxatin for Patients With Malignant Pleural or Peritoneal Mesothelioma [Phase 2]
Phase 2 trial evaluating Velcade (bortezomib) and Eloxatin (oxaliplatin) for malignant pleural or peritoneal mesothelioma. The current statu…
-
CLINICAL_TRIALS trial_result · 2007-01-26Clinical Trial Update: Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal Mesothelioma [Phase 2]
Phase 2 trial evaluating pemetrexed plus gemcitabine as first-line chemotherapy for malignant pleural or peritoneal mesothelioma.